MUC5AC and chronic obstructive pulmonary disease: After delineating mechanisms underlying HRV-increased mucin expression, we next investigated potential modulation of this process by drugs used in the treatment of asthma and COPD, and focused on the LAMA tiotropium and the ICS fluticasone.